Cargando…

The correlation between third-trimester maternal and newborn-serum 25-hydroxy-vitamin D in a selected South Australian group of newborn samples

BACKGROUND: Although vitamin D insufficiency is prevalent in the community, only a few population-based studies have measured serum 25-hydroxy-vitamin D (25OHD) levels during pregnancy and in newborns. Maternal vitamin D deficiency has been linked to pregnancy complications, as well as hypocalcaemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Sunethra Devika C, Fudge, Andrew N, Whiting, Malcolm, Coates, Penelope S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191602/
https://www.ncbi.nlm.nih.gov/pubmed/22021888
http://dx.doi.org/10.1136/bmjopen-2011-000236
_version_ 1782213680279060480
author Thomas, Sunethra Devika C
Fudge, Andrew N
Whiting, Malcolm
Coates, Penelope S
author_facet Thomas, Sunethra Devika C
Fudge, Andrew N
Whiting, Malcolm
Coates, Penelope S
author_sort Thomas, Sunethra Devika C
collection PubMed
description BACKGROUND: Although vitamin D insufficiency is prevalent in the community, only a few population-based studies have measured serum 25-hydroxy-vitamin D (25OHD) levels during pregnancy and in newborns. Maternal vitamin D deficiency has been linked to pregnancy complications, as well as hypocalcaemia and rickets in the newborn. Here, the authors report third-trimester maternal and newborn-serum 25OHD concentrations in 101 neonates whose serum samples were sent for testing. METHODS: The newborn 25OHD levels were correlated with the third-trimester maternal serum 25OHD levels using a least-square regression analysis. All samples were measured using an enzyme immunoassay (EIA). Ten randomly selected newborn serum samples were also measured using liquid chromatography/tandem mass spectrometry LC-MSMS, and correlated with the EIA method. RESULTS: Out of 99 mothers of the newborns, only 19, 42 and 68 had their 25OHD level measured in the first, second and third trimester respectively. The mean maternal age was 30 years, while the mean maternal third-trimester 25OHD concentration was 48 nmol/l. Of the newborns, 53% were female, and 85% were term deliveries. The mean newborn-serum 25OHD was 68 nmol/l. Neonatal 25OHD was related to maternal third-trimester levels measured by EIA (r=0.3; newborn 25OHD=0.42(maternal 25OHD)+44.2; p=0.02). EIA and LC-MSMS concentrations for newborns correlated significantly over a range between 20 and 103 nmol/l by EIA (r=0.9; EIA=1.04(LCMSMS)+10.1; p<0.00 (slope); p=0.18 (intercept)). The mean 25OHD concentration in women who suffered pre-eclampsia and premature rupture of membranes were 45 and 39 nmol/l respectively. CONCLUSIONS: Newborn-serum 25OHD concentrations depend on the maternal circulating plasma 25OHD level at least during the third trimester. Neonatal 25OHD levels obtained by EIA correlated well with LC-MSMS. Although the EIA values for neonates were greater than LC-MSMS values, this difference was not statistically significant.
format Online
Article
Text
id pubmed-3191602
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-31916022011-10-13 The correlation between third-trimester maternal and newborn-serum 25-hydroxy-vitamin D in a selected South Australian group of newborn samples Thomas, Sunethra Devika C Fudge, Andrew N Whiting, Malcolm Coates, Penelope S BMJ Open Reproductive Medicine, Obstetrics and Gynaecology BACKGROUND: Although vitamin D insufficiency is prevalent in the community, only a few population-based studies have measured serum 25-hydroxy-vitamin D (25OHD) levels during pregnancy and in newborns. Maternal vitamin D deficiency has been linked to pregnancy complications, as well as hypocalcaemia and rickets in the newborn. Here, the authors report third-trimester maternal and newborn-serum 25OHD concentrations in 101 neonates whose serum samples were sent for testing. METHODS: The newborn 25OHD levels were correlated with the third-trimester maternal serum 25OHD levels using a least-square regression analysis. All samples were measured using an enzyme immunoassay (EIA). Ten randomly selected newborn serum samples were also measured using liquid chromatography/tandem mass spectrometry LC-MSMS, and correlated with the EIA method. RESULTS: Out of 99 mothers of the newborns, only 19, 42 and 68 had their 25OHD level measured in the first, second and third trimester respectively. The mean maternal age was 30 years, while the mean maternal third-trimester 25OHD concentration was 48 nmol/l. Of the newborns, 53% were female, and 85% were term deliveries. The mean newborn-serum 25OHD was 68 nmol/l. Neonatal 25OHD was related to maternal third-trimester levels measured by EIA (r=0.3; newborn 25OHD=0.42(maternal 25OHD)+44.2; p=0.02). EIA and LC-MSMS concentrations for newborns correlated significantly over a range between 20 and 103 nmol/l by EIA (r=0.9; EIA=1.04(LCMSMS)+10.1; p<0.00 (slope); p=0.18 (intercept)). The mean 25OHD concentration in women who suffered pre-eclampsia and premature rupture of membranes were 45 and 39 nmol/l respectively. CONCLUSIONS: Newborn-serum 25OHD concentrations depend on the maternal circulating plasma 25OHD level at least during the third trimester. Neonatal 25OHD levels obtained by EIA correlated well with LC-MSMS. Although the EIA values for neonates were greater than LC-MSMS values, this difference was not statistically significant. BMJ Group 2011-09-12 /pmc/articles/PMC3191602/ /pubmed/22021888 http://dx.doi.org/10.1136/bmjopen-2011-000236 Text en © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Reproductive Medicine, Obstetrics and Gynaecology
Thomas, Sunethra Devika C
Fudge, Andrew N
Whiting, Malcolm
Coates, Penelope S
The correlation between third-trimester maternal and newborn-serum 25-hydroxy-vitamin D in a selected South Australian group of newborn samples
title The correlation between third-trimester maternal and newborn-serum 25-hydroxy-vitamin D in a selected South Australian group of newborn samples
title_full The correlation between third-trimester maternal and newborn-serum 25-hydroxy-vitamin D in a selected South Australian group of newborn samples
title_fullStr The correlation between third-trimester maternal and newborn-serum 25-hydroxy-vitamin D in a selected South Australian group of newborn samples
title_full_unstemmed The correlation between third-trimester maternal and newborn-serum 25-hydroxy-vitamin D in a selected South Australian group of newborn samples
title_short The correlation between third-trimester maternal and newborn-serum 25-hydroxy-vitamin D in a selected South Australian group of newborn samples
title_sort correlation between third-trimester maternal and newborn-serum 25-hydroxy-vitamin d in a selected south australian group of newborn samples
topic Reproductive Medicine, Obstetrics and Gynaecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191602/
https://www.ncbi.nlm.nih.gov/pubmed/22021888
http://dx.doi.org/10.1136/bmjopen-2011-000236
work_keys_str_mv AT thomassunethradevikac thecorrelationbetweenthirdtrimestermaternalandnewbornserum25hydroxyvitamindinaselectedsouthaustraliangroupofnewbornsamples
AT fudgeandrewn thecorrelationbetweenthirdtrimestermaternalandnewbornserum25hydroxyvitamindinaselectedsouthaustraliangroupofnewbornsamples
AT whitingmalcolm thecorrelationbetweenthirdtrimestermaternalandnewbornserum25hydroxyvitamindinaselectedsouthaustraliangroupofnewbornsamples
AT coatespenelopes thecorrelationbetweenthirdtrimestermaternalandnewbornserum25hydroxyvitamindinaselectedsouthaustraliangroupofnewbornsamples
AT thomassunethradevikac correlationbetweenthirdtrimestermaternalandnewbornserum25hydroxyvitamindinaselectedsouthaustraliangroupofnewbornsamples
AT fudgeandrewn correlationbetweenthirdtrimestermaternalandnewbornserum25hydroxyvitamindinaselectedsouthaustraliangroupofnewbornsamples
AT whitingmalcolm correlationbetweenthirdtrimestermaternalandnewbornserum25hydroxyvitamindinaselectedsouthaustraliangroupofnewbornsamples
AT coatespenelopes correlationbetweenthirdtrimestermaternalandnewbornserum25hydroxyvitamindinaselectedsouthaustraliangroupofnewbornsamples